Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.
This combination of email and password didn't match our records. Your account might not be activated. If so, please click on the link we sent you via email. You can also request a password reset or a new activation email using the links below.
4Q'25 vs. 4Q'24 Results Sales: € 458.5 M (+21.0% vs. +13.5% BS(e)); FY2025 vs. FY2024 Results Sales: € 708.5 M (+7.7% vs. +3.4% BS(e)); EBITDA: € 127.6 M (+73.8% vs. +28.1% BS(e)); Net Profit: € 56.9 M (+257.9% vs. +113.8% BS(e));
Incrementamos estimaciones y P.O. a 70,10 eur/acc. Continúa la fortaleza comercial. SOBREPONDERAR. El gran comportamiento en Bolsa en el último año (+68% en absoluto y +25% vs IBEX) es el reconocimiento a la magnífica ejecución operativa del grupo y su gran momentum comercial. A pesar de las subidas, los fundamentales siguen apoyando. Ajustamos estimaciones al alza: (i) las ventas un +c.0,5% para 2026/29, (ii) el EBIT c.+3% en 2026/29 lo que deja un margen del 6% en 2027 (desde 5,1% en 2024), (iii) rebajamos la DFN un -7% dejando un balance sólido (DFN/EBITDA’25-27e < 0,7x) que asegura la capa...
Rdos. 4T'25 vs 4T'24: Ventas: 458,5 M euros (+21,0% vs +13,5% BS(e)). Rdos. 2025 vs 2024: Ventas: 708,5 M euros (+7,7% vs +3,4% BS(e) y -34,6%); EBITDA: 127,6 M euros (+73,8% vs +28,1% BS(e)); BDI: 56,9 M euros (+257,9% vs +113,8% BS(e)).
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.